Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Club
$299/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Innovotech Inc. (V:IOT)

Business Focus: Pharmaceuticals

Get the company report for the most recent outlook updated daily
Log in or join to add this stock to your watch list.

Insider Chart - Past 6 Months

Insider Filings

Latest 10 SEDI filings for IOT within the last 6 months
Loading...
See all filings within the past 6 months

Company News

Aug 20, 2019 02:08 ET
Innovotech Inc Reports 3 and 6-month Results to June 30, 2019
Edmonton – TheNewswire - August 20, 2019. Innovotech Inc. (TSXV:IOT), a leader in contract research in connection with the susceptibility of medical devices to microbial biofilm formations, has released its financial and operating results for the three and six-month periods ended June 30, 2019.
Read full article
Jul 29, 2019 07:07 ET
Innovotech Reports Notice of Allowance of a US Patent for Antimicrobial Silver Iodates in Gels
Edmonton – TheNewswire - July 26, 2019.  Innovotech Inc. (TSXV:IOT), is pleased to report that it has received Notice of Allowance of a US patent (14/415,666) for its silver compounds, including InnovoSIL™-1 and AgreGuard™-1, which have broad activity against pathogens causing both bacterial and fungal infections.
Read full article
See more news stories

Valuation Ratios

Industry
Sector
Beta
1.02
--
--
Price to Sales - TTM
3.48
6.85
13.36
Price to Book - most recent quarter
35.90
3.02
2.81
Price to Cash Flow per share - TTM
--
8.20
13.21
Price to Free Cash Flow per share - TTM
--
7.97
19.71
See all valuations

Short Report

DateNumber of Shares ShortedNet Change
Jun 15, 201926,91826,594
May 31, 20193240
Dec 31, 196900
See Short Report

Business Summary

Sector:  Healthcare Industry:  Pharmaceuticals

Innovotech Inc is a Canada-based company, which operates in the field of biofilm product development, practical services and solutions for dealing with medical, agricultural and industrial problems caused by microbial biofilms. The Company's current products include human and veterinary biofilm susceptibility tests, a seed treatment designed to combat both bacterial and fungal diseases, and an assay used in growing microbal biofilms for research purposes. The Company's products are effective against such diseases as Powdery Mildew on lettuce, White Mould on beans, Bacterial Spot on tomatoes and Fire Blight on apples. The Company's products include InnovoSIL, MBEC Assay Agress and AgreGuard.

See business summary

Comment On!

140
Upload limit is up to 1mb only
To post messages to your Socail Media account, you must first give authorization from the websites. Select the platform you wish to connect your account to CanadianInsider.com (via Easy Blurb).

Twitter

Search (past week) for $IOT.CA IOT.V